INFI News and Press, Infinity Pharmaceuticals Inc. From 11/01/21

ADC, AFG, DADA, AIZ, AKAM, AMCR, AMED, AMGN, ANDE, APPS, AQST, ATVI, AWK, AYX, BFAM, BGFV, BKH, BTG, BXC, CASA, CDK, CDLX, CERS, CGBD, CHCT, CHK, CLW, COUR, CRK, [CSLT]], CVGI, CZR, DCP, DCPH, DENN, DHT, DOX, DRRX, [DVN]], EARN, EGHT, EIX, EKSO, ELVT, ENLC, EXAS, EXEL, FMC, FNF, FRG, GAIN, GN...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic, which addresses a fundamental biologic mechanism of immune suppression in cancer, w...

Infinity Pharmaceuticals (NASDAQ: INFI) got off to a market-beating start this week as its shares zoomed 3.8% higher Monday, on the back of new analyst coverage that made an extremely bullish case for investing in the biotech. H.C. Wainwright's Michael King Jr. is the prominent ...

ION Geophysical (NYSE:IO) +45% sees Q3 revenues more than doubling Q/Q Valneva SE (NASDAQ:VALN) +36% after topline results from late-stage VLA2001 COVID-19 trial Adamis Pharmaceuticals (NASDAQ:ADMP) +35% after FDA approves opioid overdose treatment ZIMHI MeiraGTx...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! I hope the weekend served you well because we’ve got pre-market stock movers to start off Monday with! Source: Eric Urquhart/Shutterstock.com Pharmaceutical companies are dominating toda...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, to...

– Experienced leader in immuno-oncology drug development Robert Ilaria, Jr. to head eganelisib clinical development – – Brian Schwartz, M.D., transitioning from Consulting Chief Physician to Infinity’s Board of Directors – Infinit...

Infinity Pharmaceuticals, Inc . (NASDAQ: INFI), a clinical-stage biotechnology company developing eganelisib, a potentially first-in-class, oral, immuno-oncology macrophage reprogramming therapeutic which addresses a fundamental biologic mechanism of immune suppression in cancer, to...

3 Penny Stocks to Watch As August Comes to an End Penny stocks are heating up right now. With more momentum in the stock market over the past few weeks, many investors are once again looking for the best penny stocks to buy. It can be complicated, as there are hundreds on the list of ...

Are These Biotech Penny Stocks Worth Watching Tomorrow? Finding the best biotech penny stocks to buy can be easy if investors take a few small steps. First, traders need to understand where the most value is with penny stocks in the biotech industry. Right now, this includes Covid, ...